All articles by Vidyasagar M
Vidyasagar M
Senseonics reports Glycemic outcomes from real-world Eversense CGM usage
Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and…
Co-Diagnostics receives CE Mark for Novel Coronavirus Test
Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,…
United Therapeutics and DEKA secure additional FDA clearance related to Unity Subcutaneous Delivery System for Remodulin
United Therapeutics Corporation (Nasdaq: UTHR) and DEKA Research & Development Corp. today announced receipt of an additional 510(k) clearance by…
Cerus Endovascular secures FDA approval for 021 microcatheter
US-based medical device firm Cerus Endovascular has secured the US Food and Drug Administration (FDA) approval for 021 microcatheter, which…
Karius secures $165m in Series B funding round
Liquid biopsy technology company Karius has secured $165m in a new funding round led by SoftBank Vision Fund 21. Along…
GE Healthcare rolls out medical device cybersecurity solution Skeye
Medical technology firm GE Healthcare has launched a new medical device cybersecurity solution, dubbed Skeye, to address cybersecurity threats faced…
Abbott’s FreeStyle Libre system delivers positive health outcomes for type 1 and type 2 diabetes
Abbott (NYSE: ABT) announced today that four real-world data abstractsi,ii,iii,iv are being presented during the 13th Advanced Technologies & Treatments for Diabetes (ATTD)…
UV Technology raises standard in disinfecting ORs and medical equipment
Ultraviolet (UV) technology developed by the New York-based firm PurpleSun Inc. eliminates more than 96% of pathogens in operating rooms…
RAZ Mobility introduces cell phone for memory loss patients
US-based assistive technology services provider RAZ Mobility has launched the RAZ Memory Cell Phone, for people with dementia and other…
Abbott, Insulet collaborate on integrated platform for diabetes
US-based medical devices firm Abbott has joined forces with Insulet, focused on medical devices for diabetes, to offer personalised automated…